TSS
KYNB

Two Sigma Securities’s Kyntra Bio KYNB Stock Holding History

Two Sigma Securities’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,045
Closed -$27.1K – 1686
2024
Q4 		$27.1K Buy
+2,045
New +$19K ﹤0.01% 1265
2024
Q3 		– Sell
-694
Closed -$15.5K – 3098
2024
Q2 		$15.5K Buy
694
+140
+25% +$4.33K ﹤0.01% 2749
2024
Q1 		$32.6K Sell
554
-80
-13% -$3.45K ﹤0.01% 2622
2023
Q4 		$14K Buy
634
+21
+3% +$317 ﹤0.01% 2775
2023
Q3 		$13.2K Sell
613
-37
-6% -$1.45K ﹤0.01% 2646
2023
Q2 		$43.9K Buy
+650
New +$269K ﹤0.01% 2413
2020
Q1 		– Sell
-208
Closed -$223K – 1655
2019
Q4 		$223K Buy
+208
New +$212K ﹤0.01% 2008

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Securities's KYNB Position: Q1 2025 in Review

Two Sigma Securities sold out of Kyntra Bio (KYNB) in Q1 2025, closing a stake of 2,045 shares — an estimated $27.1K sold.

Two Sigma Securities first reported a position in KYNB in Q4 2019 and held it in 7 quarters. The position peaked at $223K in Q4 2019. 54 funds tracked by Wall St. Rank hold KYNB as of Q1 2025.

  • Two Sigma Securities reported no remaining Kyntra Bio position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 2,045 Kyntra Bio shares in Q1 2025, an estimated $27.1K.
  • Two Sigma Securities first reported a position in Kyntra Bio in Q4 2019 and held it in 7 quarters.
  • Two Sigma Securities's Kyntra Bio position peaked at $223K in Q4 2019.
  • 54 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.